The IV Hydration Market in 2026

An IV hydration salon sits at the intersection of two things investors and lenders treat very differently: consumer wellness, which is discretionary and trend-driven, and clinical infusion, which is regulated medicine. Your business plan has to speak to both. The good news is that the underlying market is large and still compounding. The US intravenous hydration therapy market generated $1,121.9 million in revenue in 2025 and is forecast to grow at an 8.6% CAGR through 2033, according to Grand View Research, 2025. The United States alone accounted for 39.6% of the global market that year.

Globally the picture is the same shape. Precedence Research, 2025 sizes the worldwide IV hydration therapy market at $2.93 billion in 2025, rising to $5.84 billion by 2034 at a 7.98% CAGR, with North America holding 47% of that total in 2024. For a single-location operator this matters less as a headline number and more as a signal: demand is broad, repeat-driven, and not concentrated in a handful of metros.

Two segment facts should shape your menu. Energy boosters were the single largest service category in the US in 2025 at a 27.36% revenue share, while beauty and aesthetics drips were called out as the fastest-growing segment by Grand View Research. In plain terms, the volume sits in everyday energy and recovery formulas, but the margin growth and the social-media demand sit in the cosmetic glow and NAD+ end. A salon that builds its plan around only one of those leaves money on the table.

Demand is also seasonal and event-driven in a way generic wellness is not. Race weekends, festivals, hangover Sundays, flu season, and the run-up to weddings all spike bookings. A credible plan models that lumpiness rather than assuming a flat run rate, and it names the local demand drivers (a marathon, a convention center, a university) that a lender in your city will recognise.

The UK market is younger and is being reshaped by regulation rather than demand. Mobile and clinic-based vitamin drips have moved from a lightly governed cosmetic add-on to a regulated medical service: as of 2025 the Care Quality Commission treats IV drip therapy as the treatment of disease, disorder or injury, which means the casual beauty-salon operators who entered the space early are now either registering properly or leaving. For a serious entrant that is an opening, not an obstacle. The clinics that survive the regulatory tightening face fewer credible competitors, and a plan that builds compliance in from day one signals to a UK lender that the business is on the right side of the line. London, Manchester, and the affluent commuter belt around the major cities carry the bulk of UK demand, with mobile concierge services such as Dripdash proving that a route-based model can scale before any premises are leased.

Underneath the headline numbers, the structural tailwind is repeat behaviour. Unlike a one-off cosmetic procedure, hydration and vitamin therapy is something a satisfied customer comes back for monthly, which is why the category supports memberships at all. That repeat dynamic is what turns a modest market share in a single city into a defensible, compounding revenue base, and it is the single most important thing to evidence when a plan is read by someone deciding whether to lend against it.

Funding the Build: SBA and Lender Reality

An IV hydration salon is classified as an ambulatory or miscellaneous health practitioner business, which lands it under NAICS code 621399 (Offices of All Other Miscellaneous Health Practitioners). That matters for one practical reason: healthcare consistently posts some of the highest SBA approval rates of any sector, typically in the 72–80% range for qualified applicants, per Crestmont Capital, 2026. The SBA size standard for 621399 is $10.0 million in average annual receipts (US Small Business Administration), so almost every startup salon comfortably qualifies as a small business.

The financing route you choose tends to track your build:

• SBA 7(a) loan (up to $5M): the workhorse for a storefront drip bar. Lenders will want a signed medical director agreement, a lease or letter of intent, and a forecast that shows debt service coverage above 1.25x. A clinically credible plan moves you toward the top of that 72–80% band rather than the bottom.
• SBA microloan or equipment financing: a better fit for a mobile-first launch where the main assets are a vehicle kit, chairs, and a point-of-care setup. Equipment financing keeps the loan secured against assets and preserves cash for consumables.
• UK Start Up Loans (up to £25,000 at 6% fixed): government-backed personal loans that fund a first UK clinic, frequently stacked with a commercial overdraft. These are reviewed centrally, so the plan quality and the CQC registration evidence do the persuading.

There is a credibility tax specific to this niche that a good plan pays down. Because the press cycle around IV therapy includes the occasional adverse-event headline, an underwriter looking at a "drip bar" application is primed to ask whether the operator is a wellness amateur or a clinical professional. The plan answers that question in the first two pages or it does not get read closely. Naming the medical director, attaching the signed agreement, citing the relevant state statute, and showing a documented consent and protocol workflow does more to move an application toward approval than another decimal place on the revenue forecast. Treat the compliance evidence as a financing asset, not a box to tick.

One number lenders quietly test for: the gap between your opening cash and your break-even month. The guides at LocumTele, 2026 put mobile break-even at 3 to 6 months and storefront break-even at 9 to 18 months. If your requested loan does not cover operating runway through that window, the application reads as under-capitalised regardless of how good the concept is.

What It Costs to Open the Doors

The single most useful thing this plan can do is separate the two builds, because they are different businesses with different capital needs. A mobile IV service launches for roughly $8,000 to $25,000, while a fixed storefront drip bar runs $20,000 to $80,000 and up once fit-out is included, per LocumTele, 2026. In the UK, expect roughly £12,000 to £65,000 across the same spectrum once CQC registration and a prescriber arrangement are funded.

Line-Item Breakdown

• Premises lease and fit-out (storefront only): $7K–$30K (£6K–£24K) for a treatment room, comfortable recliners, and a clean clinical finish
• Medical director agreement and standing orders: $500–$2,000 per month (£400–£1,600 equivalent prescriber engagement) plus initial protocol drafting
• Clinical equipment: infusion poles, recliner chairs, vitals monitors, a medical-grade refrigerator, and a sharps and medical-waste contract
• Opening consumables: $3K–$10K of sterile saline, vitamin and mineral additives, B12, glutathione, tubing, and PPE
• Insurance: professional liability and general liability in the US; professional indemnity plus £1M+ public liability in the UK
• Booking, payments and EHR: a platform such as Jane App or Vagaro, plus a card processor and an intake and consent workflow
• Launch marketing: $2K–$10K for brand, photography, a booking-ready site, and local social campaigns

Funding Routes

In the US, the practical stack is an SBA 7(a) loan for a storefront or equipment financing plus an SBA microloan for a mobile launch, often combined with founder savings. In the UK, Start Up Loans (up to £25,000 at 6% fixed) and a commercial overdraft are the common starting point. Whichever route you take, the lender is underwriting the medical director arrangement and the runway as much as the concept. See our market research and content service if you want those figures built for your specific city.

Mobile vs Storefront vs Membership

Most failed IV salons picked the wrong format before they understood their demand. The three viable models are not just different price points; they have different cash profiles, different staffing, and different regulatory exposure. The plan should commit to one as the launch model and name the trigger that moves you to the next.

The format also changes who you compete with. Independents usually start mobile to prove a route, then move into a lease. Franchises skip that step and buy a tested storefront playbook at a much higher entry price: Hydrate IV Bar quotes a $238,000 to $454,000 total investment with $125,000 liquid capital required, Prime IV Hydration & Wellness lists $157,902 to $376,902, and The DRIPBaR and Vida-Flo sit in the $140,000 to $340,000 band. If your plan targets under $80,000 to launch, you are explicitly choosing the independent path, and the plan should say why that capital efficiency is an advantage rather than a gap.

A membership layer is the quiet differentiator. Brands such as the UK mobile service Dripdash and the franchised lounges all push packages because a member who prepays four drips a month converts a discretionary purchase into recurring revenue, which is exactly what lenders and acquirers pay a premium for.

Drip Economics and Margin

This is the section most templates get wrong, because they quote a market net margin instead of building it from the chair up. IV salon economics are simple once you separate the ticket from the cost. Published menus put a basic saline-and-electrolyte hydration drip at $100 to $150, vitamin and energy drips at $150 to $250, and a Myers' Cocktail style immunity formula at $150 to $300, with NAD+ therapy reaching premium pricing of up to $999, per Onus IV, 2025. B12 and other injectable add-ons sell for $20 to $50 each and carry almost pure margin.

A Worked Example

Take a four-chair storefront delivering an average of 9 drips per day at a $185 blended ticket, open 26 days a month. That is roughly $43,300 in monthly gross revenue. If the direct consumable cost per drip averages about $75, gross margin lands near 60%, leaving roughly $26,000 of contribution before the medical director retainer, rent, and clinical payroll. Layer in 60 members each prepaying $160 a month and you add about $9,600 of high-visibility recurring revenue on top, which is what shortens the break-even window from the 9-to-18-month storefront range toward its lower end.

Per-session gross margins of 55% to 75% are realistic, but net margin is decided almost entirely by chair utilisation and the director retainer. A plan that shows 9 drips a day is credible; one that assumes 25 with no waiting-room math is not, and a lender will catch it. The reason this matters is that the cost structure is heavily fixed once you are open: the medical director retainer, the lease, and at least one nurse on the clock are paid whether you deliver 3 drips or 13. That is why utilisation, not pricing, is the lever that turns the business profitable, and why the forecast should run a low, base, and high case keyed to drips per day rather than to a single optimistic number.

A useful sanity check for any IV salon forecast is the contribution per chair-hour. If a $185 ticket carries roughly $75 of consumable cost and occupies a chair for 45 minutes, the chair is generating about $147 of gross contribution per hour it is full. Multiply that by realistic occupied hours per chair per week, subtract the fixed costs, and the break-even point falls out honestly. Most first-time plans skip this step and instead reverse-engineer revenue from a target profit, which is exactly the pattern an experienced lender is trained to distrust. Common revenue streams to model alongside core drips:

• Injectable add-ons: B12, glutathione, and vitamin D shots at $20–$50, sold at the chair
• Memberships and prepaid packages: monthly plans that smooth seasonality and lift retention
• Mobile and event bookings: premium-priced group drips for weddings, corporate offices, and race weekends
• Retail supplements: a small, high-margin shelf of recovery and immunity products

Who Actually Books a Drip

Generic plans describe the customer as "wellness-focused adults," which tells a lender nothing. IV hydration demand clusters into four distinct buyers, each with a different trigger, ticket, and acquisition cost. Your plan should name which two you are building for first, because that decision drives your location, your menu, and your hours.

• Recovery and hangover bookings: the highest-frequency, lowest-loyalty segment. They convert on speed and proximity, peak on weekends and after local events, and respond to last-minute mobile availability more than to brand.
• Athletes and performance clients: recurring, margin-friendly buyers who value electrolyte and amino formulas. They cluster around gyms, CrossFit boxes, and race calendars, and they are the natural core of a membership base.
• Wellness and beauty regulars: the fastest-growing segment per Grand View Research, drawn to glutathione, NAD+, and "glow" drips. They have the highest lifetime value and the strongest social-media pull, but they expect a polished clinical environment.
• Immunity and clinical-adjacent clients: people managing fatigue, frequent travel, or recovery from illness. They skew older, book in advance, and value the medical credibility your director provides.

The practical implication is geographic. A salon near a stadium and a nightlife strip lives on recovery volume; one in an affluent suburb near boutique fitness studios lives on memberships and beauty drips. A plan that maps the menu and the catchment to specific segments converts far better in front of a lender than one that lists "men and women aged 25 to 55."

Running the Chair-Hour

In this business, the unit of production is the chair-hour, and almost every operational decision either fills it or wastes it. A drip takes 30 to 60 minutes, so a four-chair lounge has a hard ceiling on how many sessions it can deliver in a day. The operations section of your plan should show you understand that ceiling and how you keep it occupied.

• Scheduling and intake: a booking platform such as Jane App or Vagaro handles appointments, intake forms, and consent. Tight scheduling, deposits, and a short pre-visit screening reduce the no-shows that quietly destroy chair utilisation.
• Clinical workflow: standardised protocols signed by the medical director, a documented consult and consent step, and clear delegation of who places the line and who monitors. This is both a safety control and a regulatory one.
• Inventory and cold chain: sterile saline, vitamin and mineral additives, and biologics like glutathione have shelf lives and storage requirements. A par-level reorder system and a medical-grade refrigerator prevent the spoilage that erodes the consumable margin.
• Waste and compliance: a sharps and clinical-waste contract, infection-control procedures, and an adverse-event log that the medical director reviews. Regulators hold the director responsible, so this has to be real, not decorative.

The metrics a serious operator tracks weekly are utilisation per chair, average ticket, consumable cost per drip, no-show rate, and membership count. A plan that names those five and sets year-one targets for each reads as written by someone who has thought past opening day.

Filling the Calendar

Acquisition for an IV salon is unusually local and unusually visual, which is good news because both are cheap to exploit well. The plan should tie each channel to a cost per booking and a payback assumption rather than listing tactics.

• Local search and maps: a Google Business Profile with real photos and reviews is the highest-intent channel. People searching "IV drip near me" on a Saturday morning are ready to book now, and ranking locally beats any paid campaign on cost per acquisition.
• Social proof and partnerships: short before-and-after and behind-the-chair content, plus partnerships with gyms, salons, hotels, and event planners who refer the recovery and event segments.
• Memberships and retention: the cheapest revenue is a repeat one. A prepaid monthly plan converts a one-off recovery booking into predictable income and turns the marketing spend from acquisition into retention.
• Event and corporate channels: mobile drips for weddings, race expos, and corporate offices carry premium pricing and seed word-of-mouth among exactly the wellness and athlete segments you want as members.

The forecast should connect these channels to customer acquisition cost, conversion rate, and repeat-purchase assumptions so the revenue line is grounded in a real acquisition model rather than a hopeful growth curve. Where a founder spends the first 90 days of marketing time, and which segment they chase first, often decides whether the break-even month lands at the optimistic or the pessimistic end of the range.

Who Is Legally Allowed to Run This

This is the line that separates an IV hydration salon from a nail bar: it administers a prescription medical treatment, so a non-clinician cannot simply open one. The rules differ sharply by jurisdiction, and your launch state or country decides your org chart before your brand does.

The reason this section sits at the heart of the plan rather than in an appendix is that it determines your cost base and your hiring before anything else. A founder who is a registered nurse still needs a contracted physician; a founder who is neither needs both. Each layer of clinical staffing is a recurring cost that the financial model has to carry from month one, and getting the structure wrong is the most common reason an otherwise attractive IV salon plan is rejected or, worse, opens and is shut down. The summary below is a starting map, not legal advice, and the launch jurisdiction should always be confirmed with a healthcare attorney before the lease is signed.

United States

• Medical director: nearly every state requires a physician (MD or DO) to own or oversee the clinical protocols, sign standing orders, and approve every formula. RNs generally cannot operate independently (Cohen Healthcare Law).
• Texas HB 3749, "Jenifer's Law": effective September 1, 2025, elective IV therapy may only be ordered by a physician, NP, or PA, and administration may be delegated to RNs but never to unlicensed staff (Nurse.org, 2025).
• Florida: RNs may administer IV therapy only after completing a 30-hour IV certification course (Nextech).
• Across states: business license and DBA, state health department permits, sales tax registration, and professional plus general liability insurance.

United Kingdom

• CQC registration: IV drip therapy is now regulated as the "treatment of disease, disorder or injury," so providers must register with the Care Quality Commission before operating (Care 4 Quality).
• Prescriber requirement: the vitamins and additives are prescription-only medicines, so an independent prescriber (doctor, dentist, or prescribing nurse or pharmacist) must complete a face-to-face consultation and issue a prescription order before a non-medic administers it.
• Insurance and data: professional indemnity, £1M+ public liability, and ICO data-protection registration.

Other Jurisdictions

• Canada: provincial nursing-college oversight; RN-delivered infusions need a physician medical directive, plus federal business registration and workers' compensation cover.
• EU: prescription-only medicine rules under national medicines law and CE marking for the infusion kit, alongside GDPR compliance.

Because the medical director or prescriber is both a legal requirement and a recurring cost, it belongs in the management section and the financials, not buried in a compliance footnote. Lenders read its absence as the single biggest red flag in this niche.

Where First-Time Operators Lose Money

After reviewing plans across the wider healthcare and wellness sector, the same avoidable errors show up in IV salon proposals. Naming them in your plan signals to a lender that you have done the homework.

• Treating it as beauty, not medicine: skipping the medical director or assuming an RN can own the clinical side. This is the fastest route to a regulator shutdown and a declined loan.
• Pricing off competitors instead of off cost: matching the salon down the road without building the ticket up from the ~$75 consumable cost and the chair-hour. Margin disappears quietly.
• Ignoring state divergence: a model copied from a Florida operator may be illegal in Texas under HB 3749. The launch state's rules come first.
• Under-budgeting waste and disposal: consumable spoilage, expired vitamins, and a sharps and clinical-waste contract are real recurring costs that founders routinely omit.
• Building a storefront before proving demand: committing to a $20K–$80K lease when a $8K–$25K mobile route could have validated the catchment first.

Sample Business Plan Preview

Here is the structure and the financial output a buyer receives. These mockups use the same drip-economics assumptions described above.

What's in the Template

Every Avvale business plan template is pre-structured for your industry. For an IV hydration salon, that means the clinical and regulatory sections are built in, not bolted on:

• Executive Summary — the concept, the format you are launching, and the funding ask in 60 seconds
• Company & Clinical Governance — legal structure plus the medical director or prescriber arrangement
• Industry Analysis — market size, segment trends, and local demand drivers
• Customer Analysis — athletes, wellness regulars, event clients, and recovery seekers
• Competitor Analysis — independents, franchises, and mobile services in your catchment
• Marketing Plan — local search, social proof, memberships, and referral loops
• Operations Plan — chair scheduling, consumables, waste handling, and intake workflow
• Management Team — founder, medical director, and clinical staff plan

The optional Financial Forecast add-on (included in our $300/£250 and $1,000/£800 packages) provides a 5-year Excel model with income statement, cash flow, balance sheet, break-even analysis, and startup capital requirements built on the drip economics above. Browse our free business plan templates or compare a related niche such as our medical spa business plan template.

Frequently Asked Questions

Useful Links & Resources

These links were preserved from the live page so important references and partner links are not lost during the page refresh.

• Facebook
• Instagram
• LinkedIn
• YouTube